The genealogy company is in the "very early stages of a conversation with the FDA," according to Ancestry.com CEO Tim Sullivan.
Ancestry.com, the popular genealogy site, is talking to the FDA about using DNA to estimate disease risk for the company's member base. CEO Tim Sullivan revealed the news in an interview with The Verge, effectively announcing his company's intention to eventually offer straight-to-consumer genetic testing.
No comments:
Post a Comment